Oocyte quality in polycystic ovaries revisited: Identification of a particular subgroup of women

Journal of Assisted Reproduction and Genetics

Volumn 14, Issue 5, 1997, Pages 254-261

  Cano, Fidel ^a   García Velasco, Juan A ^a   Millet, Antón ^b   Remohí, José ^a   Simón, Carlos ^a,b   Pellicer, Antonio ^a,b  

^a INSTITUTO VALENCIANO DE INFERTILIDAD   (Spain)

^b NONE

Author keywords

glucose; in vitro fertilization; insulin; insulin resistance; oocyte quality; polycystic ovary

Indexed keywords

ANDROSTENEDIONE; ESTRADIOL VALERATE; FOLLITROPIN; LUTEINIZING HORMONE; MEDROXYPROGESTERONE ACETATE; PRASTERONE SULFATE;

ADULT; ANDROGEN BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FERTILIZATION; FERTILIZATION IN VITRO; FOLLITROPIN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HORMONE RESPONSE; HUMAN; INSULIN BLOOD LEVEL; INSULIN RELEASE; LUTEINIZING HORMONE BLOOD LEVEL; NIDATION; OBESITY; OOCYTE; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030916267     PISSN: 10580468     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02765826     Document Type: Article

References (25)

1. Salat-Baroux J, Alvarez S, Antoine JM, Comet D, Tibi Ch, Plachot M, Mandelbaum J: Results of IVF in the treatment of polycystic ovary disease. Hum Reprod 1988;3:331-335
2. Dor J, Shulman A, Levran D, Ben-Rafael Z, Rudak E, Mashiach S: The treatment of patients with polycystic ovarian syndrome by in-vitro fertilization and embryo transfer: A comparison of results with those of patients with tubal infertility. Hum Reprod 1990;5:816-818
3. MacDougall MJ, Tan SL, Balen A, Jacobs HS: A controlled study comparing patients with and without polycystic ovaries undergoing in-vitro fertilization. Hum Reprod 1993;8:233-237
4. Carmina E, Koyama T, Chang L, Stanczyk FZ, Lobo RA: Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome? Am J Obstet Gynecol 1992;167:1807-1812
5. Balen AH, Conway GS, Kaltsas G, Techatraisak K, Manning PJ, West Ch, Jacobs HS: Polycystic ovary syndrome: The spectrum of the disorder in 1741 patients. Hum Reprod 1995;10:2107-2111
6. Poison DW, Wadsworth J, Adams J, Franks S: Polycystic ovaries-a common finding in normal women. Lancet 1988;2:870-872
7. Wong IL, Morris RS, Lobo RA, Paulson RJ, Sauer MV: Isolated polycystic morphology in ovum donors predicts response to ovarian stimulation. Hum Reprod 1995;10:524-528
8. Pellicer A, Ruiz A, Castellví RM, Calatayud C, Ruiz M, Tarín JJ, et al.: Is the retrieval of high numbers of oocytes desirable in patients treated with gonadotrophin-releasing hormone analogues (GnRHa) and gonadotrophins?. Hum Reprod 1989;4:536-540
9. Testart J, Belaisch-Allart J, Forman R, Gazengel A, Hazout A, Strubb N, Frydman R: Influence of different stimulation treatments on oocyte characteristics and in vitro fertilizing ability. Hum Reprod 1989;4:192-197
10. Remohí J, Vidai A, Pellicer A: Oocyte donation in low responders to conventional ovarian stimulation for in vitro fertilization. Fertil Steril 1993;59:1208-1215
11. Ashkenazi J, Farhi J, Orvieto R, Homburg R, Dekel A, Feldberg D, Ben Rafael Z: Polycystic ovary syndrome patients as oocyte donors: the effect of ovarian stimulation protocol on the implantation rate of the recipient. Fertil Steril 1995;64:564-567
12. Simon C, Cano F, Valbuena D, Remohí J, Pellicer A: Clinical evidence for a detrimental effect on uterine receptivity of high serum estradiol levels in high and normal responder patients. Hum Reprod 1995;10:2432-2437
13. Hardy K, Robinson FM, Paraschos T, Wicks R, Franks S, Winston RML: Normal development and metabolic activity of preimplantation embryos in vitro from patients with polycystic ovaries. Hum Reprod 1995;10:2125-2135
14. WHO:. Laboratory Manual for the Examination of Human Semen and Sperm-Cervical Mucus Interaction, 3rd ed. Cambridge, Cambridge University Press, 1992, IA, pp 43-44
15. Pasquali R, Antenucci D, Venturoli S, et al.: Insulin resistance in patients with polycystic ovaries: its relationship to body weight and androgen levels. Acta Endocrinol (Copenh) 1983;104:110-116
16. Dunaif A, Segal KR, Shelley DR, Green G, Dobrjansky A, Licholai T: Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome. Diabetes 1992;41:1257-1266
17. Willis D, Franks S: Insulin action in human granulosa cells from normal and polycystic ovaries is mediated by the insulin receptor and not the type-I insilin-like growth factor receptor. J Clin Endocrinol Metab 1995;80:3788-3790
18. Baulieu EE: Induction by progesterone and a "maturation-promoting factor" of soluble protein in xenopus laevis oocytes in vitro. Ann NY Acad Sci 1977;286:421-433
19. Silverberg KM, Bums WN, Olive DL, Riehl RM, Schenken RS: Serum progesterone levels predict success of in vitro fertilization/embryo transfer in patients stimulated with leuprol-ide acetate and human menopausal gonadotropins. J Clin Endocrinol Metab 1991;73:797-803
20. Andersen CY: Characteristics of human follicular fluid associated with successful conception after in vitro fertilization. J Clin Endocrinol Metab 1993;77:1227-1234
21. Gómez E, Tarín JJ, Pellicer A: Oocyte maturation in humans: Effect of gonadotropins and growth factors. Fertil Steril 1993;60:40-46
22. Filicori M, Flamigni C, Cognigni G, Dellai P, Michelacci L, Arnone R: Increased insulin secretion in patients with multifollicular and polycystic ovaries and its impact on ovulation induction. Fertil Steril 1994;62:279-285
23. Homburg R: Polycystic ovary syndrome - from gynaecological curiosity to multisystem endocrinopathy. Hum Reprod 1996;11:29-39
24. Homburg R, Armar NA, Eshel A, Adams J, Jacobs HS: Influence of serum luteinising hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome. Br Med J 1988;297:1024-1026
25. Pellicer A, Valbuena D, Cano F, Remohí J, Simon C: Lower implantation rates in high responders: Evidence for an altered endocrine milieu during the pre-implantation period. Fertil Steril 1996;65:1190-1195